Monica T. Posgai
Research Subjects
Monica T. Posgai has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Andrew B. Herr
Division of Immunobiology, Cincinnati Children’s Hospital Medical Center
1 shared publication - George M. Ibrahim
Division of Neurosurgery The Hospital for Sick Children Toronto Ontario Canada
1 shared publication - George Stan
Department of Chemistry, University of Cincinnati, Cincinnati, OH 45221, United States
1 shared publication Julian Quintero
R&D, Johnson & Johnson MedTech Raritan New Jersey USA
1 shared publication- Jörg Tomaszewski
Global Medical Affairs, Johnson & Johnson MedTech Raritan New Jersey USA
1 shared publication Manori Jayasinghe
Department of Mathematics, Physics and Computer Science, University of Cincinnati Blue Ash College, Blue Ash, OH 45236
1 shared publication
Latest Publications
- Open Access
- 8 September 2026
- Published by Wiley in Contact Dermatitis
- Vol. 95 (5) , 526-527
Rouhani et al. ‘Formaldehyde Emissions From 2‐Octyl Cyanoacrylate: Quantified Risk for Allergic Contact Dermatitis’
- 8 September 2026
- Published by Wiley in Contact Dermatitis
- Vol. 95 (5) , 526-527
Open AccessRouhani et al. ‘Formaldehyde Emissions From 2‐Octyl Cyanoacrylate: Quantified Risk for Allergic Contact Dermatitis’
- 4 September 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (38) , E8882-E8891
FcαRI binding at the IgA1 CH2–CH3 interface induces long-range conformational changes that are transmitted to the hinge region
IgA effector functions include proinflammatory immune responses triggered upon clustering of the IgA-specific receptor, FcαRI, by IgA immune complexes. FcαRI binds to the IgA1–Fc domain (Fcα) at the CH2–CH3 junction and, except for CH2 L257 and L258, all side-chain contacts are contributed by the CH3 domain. In this study, we used experimental and computational approaches to elucidate energetic and conformational aspects of FcαRI binding to IgA. The energetic contribution of each IgA residue in the binding interface was assessed by alanine-scanning mutagenesis and equilibrium surface plasmon resonance (SPR). As expected, hydrophobic residues central to the binding site have strong energetic contributions to the FcαRI:Fcα interaction. Surprisingly, individual mutation of CH2 residues L257 and L258, found at the periphery of the FcαRI binding site, dramatically reduced binding affinity. Comparison of antibody:receptor complexes involving IgA or its precursor IgY revealed a conserved receptor binding site at the CH2–CH3 junction (or its equivalent). Given the importance of residues near the CH2–CH3 junction, we used coarse-grained Langevin dynamics simulations to understand the functional dynamics in Fcα. Our simulations indicate that FcαRI binding, either in an asymmetric (1:1) or symmetric (2:1) complex with Fcα, propagated long-range conformational changes across the Fc domains, potentially impacting the hinge and Fab regions. Subsequent SPR experiments confirmed that FcαRI binding to the Fcα CH2–CH3 junction altered the kinetics of HAA lectin binding at the IgA1 hinge. Receptor-induced long-distance conformational transitions have important implications for the interaction of aberrantly glycosylated IgA1 with anti-glycan autoantibodies in IgA nephropathy. Significance Antibodies binding to their cognate cellular receptors can trigger important downstream immune responses. We mapped out critical amino acids on the IgA1 antibody that govern binding to its specific receptor, FcαRI. We found that two of the most important amino acids were located on a different IgA1 domain than the rest of the binding site, separated by a flexible linker. To better understand the interplay between receptor binding and dynamic motions in IgA1, we conducted dynamics simulations on the system. The results indicate that receptor binding perturbs IgA1 conformational dynamics over long distances and can link the receptor binding site to the hinge region of IgA1. We validate this finding experimentally, which has implications for the kidney disease IgA nephropathy.
- 4 September 2018
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (38) , E8882-E8891
FcαRI binding at the IgA1 CH2–CH3 interface induces long-range conformational changes that are transmitted to the hinge region
IgA effector functions include proinflammatory immune responses triggered upon clustering of the IgA-specific receptor, FcαRI, by IgA immune complexes. FcαRI binds to the IgA1–Fc domain (Fcα) at the CH2–CH3 junction and, except for CH2 L257 and L258, all side-chain contacts are contributed by the CH3 domain. In this study, we used experimental and computational approaches to elucidate energetic and conformational aspects of FcαRI binding to IgA. The energetic contribution of each IgA residue in the binding interface was assessed by alanine-scanning mutagenesis and equilibrium surface plasmon resonance (SPR). As expected, hydrophobic residues central to the binding site have strong energetic contributions to the FcαRI:Fcα interaction. Surprisingly, individual mutation of CH2 residues L257 and L258, found at the periphery of the FcαRI binding site, dramatically reduced binding affinity. Comparison of antibody:receptor complexes involving IgA or its precursor IgY revealed a conserved receptor binding site at the CH2–CH3 junction (or its equivalent). Given the importance of residues near the CH2–CH3 junction, we used coarse-grained Langevin dynamics simulations to understand the functional dynamics in Fcα. Our simulations indicate that FcαRI binding, either in an asymmetric (1:1) or symmetric (2:1) complex with Fcα, propagated long-range conformational changes across the Fc domains, potentially impacting the hinge and Fab regions. Subsequent SPR experiments confirmed that FcαRI binding to the Fcα CH2–CH3 junction altered the kinetics of HAA lectin binding at the IgA1 hinge. Receptor-induced long-distance conformational transitions have important implications for the interaction of aberrantly glycosylated IgA1 with anti-glycan autoantibodies in IgA nephropathy. Significance Antibodies binding to their cognate cellular receptors can trigger important downstream immune responses. We mapped out critical amino acids on the IgA1 antibody that govern binding to its specific receptor, FcαRI. We found that two of the most important amino acids were located on a different IgA1 domain than the rest of the binding site, separated by a flexible linker. To better understand the interplay between receptor binding and dynamic motions in IgA1, we conducted dynamics simulations on the system. The results indicate that receptor binding perturbs IgA1 conformational dynamics over long distances and can link the receptor binding site to the hinge region of IgA1. We validate this finding experimentally, which has implications for the kidney disease IgA nephropathy.